BOB体育

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how safe and effective upadacitinib is in treating adult participants with moderately to severely active鈥�

Investigator

Michael R Bubb

Ages

18 Years - 63 Years

Sexes

All

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study will focus on participants who have active disease and are already taking standard of care鈥�

Investigator

Michael R Bubb

Ages

18 Years - N/A

Sexes

All